H

Haraprasad

Active Director Designated Partner DIN 10561431
DIN 10561431 First appointment Mar 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Haraprasad

Data last updated:

Haraprasad is a Designated Partner at North East Pharma Blr Limited Liability Partnership (since 2024).

DIN 10561431
Primary Designation Designated Partner
First Appointment 22 Mar 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner22 Mar 20242024Active

Directorship timeline

Open interactive timeline →
North East Pharma Blr Limited Liability Partnership
Premium access

Shareholding and investment profile for Haraprasad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Haraprasad

Haraprasad currently holds 1 directorship: North East Pharma Blr Limited Liability Partnership (Designated Partner, since 22 Mar 2024).

Haraprasad was first appointed on 22 Mar 2024 as Designated Partner at North East Pharma Blr Limited Liability Partnership.

The current boards of Haraprasad's companies include Basavarajappa Sreekantamurthy (North East Pharma Blr Limited Liability Partnership), Chikkamuniappa Jayaramaiah (North East Pharma Blr Limited Liability Partnership), Muniyappa Aras (North East Pharma Blr Limited Liability Partnership), Vittal Vasudeva Rao (North East Pharma Blr Limited Liability Partnership).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available